Increase in adiposity from childhood to adulthood predicts a metabolically obese phenotype in normal-weight adults

被引:0
|
作者
A. Viitasalo
N. Pitkänen
K. Pahkala
T. Lehtimäki
J. S. A. Viikari
O. Raitakari
T. O. Kilpeläinen
机构
[1] University of Copenhagen,Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences
[2] University of Turku,Research Centre of Applied and Preventive Cardiovascular Medicine
[3] University of Turku and Turku University Hospital,Centre for Population Health Research
[4] University of Turku,Paavo Nurmi Centre, Sports and Exercise Medicine Unit, Department of Physical Activity and Health
[5] Fimlab Laboratories,Department of Clinical Chemistry
[6] Tampere University,Faculty of Medicine and Health Technology, Finnish Cardiovascular Research Center
[7] University of Turku and Division of Medicine,Department of Medicine
[8] Turku University Hospital,Department of Clinical Physiology and Nuclear Medicine
[9] Turku University Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Normal weight is associated with a favorable cardiometabolic risk profile and low risk of type 2 diabetes and cardiovascular disease. However, some normal-weight individuals—the “metabolically obese normal weight” (MONW)—show a cardiometabolic risk profile similar to the obese. Previous studies have shown that older age, central body fat distribution, and unfavorable lifestyle increase the risk of MONW. However, the role of early-life factors in MONW remains unknown. We examined the associations of early-life factors with adult MONW in 1178 individuals from the Cardiovascular Risk in Young Finns study who were followed up from childhood to adulthood. The strongest early predictor for adult MONW was an increase in BMI from childhood to adulthood (p = 3.1 × 10−11); each 1 SD increase in BMI z-score from childhood to adulthood led to a 2.56-fold increase in the risk of adult MONW (CI 95% = 1.94–3.38). Other significant predictors of adult MONW were male sex (OR = 2.38, 95% = 1.63–3.47, p = 7.0 × 10−6), higher childhood LDL cholesterol (OR = 1.41 per 1 SD increase in LDL cholesterol, CI 95% = 1.14–1.73, p = 0.001), and lower HDL cholesterol (OR = 1.51 per 1 SD decrease in HDL cholesterol, CI 95% = 1.23–1.85, p = 5.4 × 10−5). Our results suggest that an increase in adiposity from childhood to adulthood is detrimental to cardiometabolic health, even among individuals remaining normal weight.
引用
收藏
页码:848 / 851
页数:3
相关论文
共 50 条
  • [31] Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population
    Zheng, Qianqian
    Lin, Weihua
    Liu, Chengguo
    Zhou, Yaohan
    Chen, Tianhui
    Zhang, Liqun
    Zhang, Xuhui
    Yu, Senhai
    Wu, Qiong
    Jin, Ziqi
    Zhu, Yimin
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [32] Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans
    Choi, Kyung Mook
    Cho, Hyun Joo
    Choi, Hae Yoon
    Yang, Sae Jeong
    Yoo, Hye Jin
    Seo, Ji A.
    Kim, Sin Gon
    Baik, Sei Hyun
    Choi, Dong Seop
    Kim, Nan Hee
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 79 (03) : 364 - 370
  • [33] Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects
    Guerrero-Romero, Fernando
    Rodriguez-Moran, Martha
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (07) : 639 - 643
  • [34] Metabolically Obese Normal-Weight Phenotype as a Risk Factor for High Blood Pressure: A Five-Year Cohort
    Vera-Ponce, Victor Juan
    Guerra, Jamee Valencia
    Torres-Malca, Jenny Raquel
    Zuzunaga-Montoya, Fiorella E.
    Loayza-Castro, Joan A.
    Guillen, Norka Rocio Ponce
    Zenas-Trujillo, Gianella Zulema
    Valladares-Garrido, Mario J.
    Ramos, Willy Cesar Munoz
    De La Cruz-Vargas, Jhony A.
    [J]. JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2023, 13 (01) : 13 - 19
  • [35] Metabolically Healthy Obese and Metabolically Abnormal but Normal-Weight in Hispanic and Non-Hispanic Populations
    Serrano-Rios, Manuel
    Lorenzo, Carlos
    Martinez-Larrad, Maria T.
    Gonzalez-Villalpando, Clicerio
    Gabriel, Rafael
    Haffner, Steven M.
    [J]. DIABETES, 2009, 58 : A267 - A267
  • [36] Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance
    Gao, Xin-Yuan
    Kuang, Hong-Yu
    Liu, Xiao-Min
    Wang, Xue-Yan
    Pan, Yan-Hui
    Ma, Xiao-Xia
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) : E5 - E6
  • [37] Adiposity is related to decrements in cardiorespiratory fitness in obese and normal-weight children
    Tsiros, M. D.
    Coates, A. M.
    Howe, P. R. C.
    Walkley, J.
    Hills, A. P.
    Wood, R. E.
    Buckley, J. D.
    [J]. PEDIATRIC OBESITY, 2016, 11 (02): : 144 - 150
  • [38] Population pharmacokinetics of omeprazole in obese and normal-weight adults
    Chen, Kaifeng
    Luo, Ping
    Yang, Guoping
    Zhu, Shaihong
    Deng, Chenhui
    Ding, Junjie
    Lin, Yaqi
    Zhu, Liyong
    Pei, Qi
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (04) : 461 - 471
  • [39] Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman
    Hyun, Y. J.
    Koh, S. J.
    Chae, J. S.
    Kim, J. Y.
    Kim, O. Y.
    Lim, H. H.
    Jang, Y.
    Park, S.
    Ordovas, Jose M.
    Lee, J. H.
    [J]. OBESITY, 2008, 16 (04) : 784 - 789
  • [40] Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals
    Aung, Koko
    Lorenzo, Carlos
    Hinojosa, Marco A.
    Haffner, Steven M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (02): : 462 - 468